Latest Orphan drugs Stories
A previously invincible mutation in chronic myeloid leukemia (CML) has been thwarted by an investigational drug called ponatinib in a phase I clinical trial.
A new study has found Acute Myeloid Leukaemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent less likely to die from their disease.
"Thanks to my Cancer" is a creative film where the most unusual ways are used to make you realize that Surviving is about Fighting. Fort Collins, CO